Annual EBITDA
$100.16M$167.99M+247.67%
Summary
- Current Value
- As of today, ACAD annual EBITDA is $100.16M, up +247.67% on
- Historical Performance
- ACAD annual EBITDA is up +159.94% over the past 3 years, and up +141.09% over the past 5 years
- All-Time High Comparison
- ACAD annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ACAD annual EBITDA is +145.21% above its 3-year low of -$221.57M reached on an earlier date
- Sector Comparison
- ACAD annual EBITDA is higher than 86.36% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $100.16M | +247.7% | +159.9% | +141.1% | +325.8% | |
| Quarterly EBITDA | $38.71M | +13.1% | +227.5% | +219.6% | +1034.7% | |
| TTM EBITDA | $108.46M | -12.9% | +149.3% | +149.2% | +626.6% | |
| Price | $27.42 | +57.7% | +58.5% | -50.1% | +2284.3% | |
| PE Ratio | 17.64 | +37.9% | – | – | +498.0% | |
| Annual Revenue | $957.80M | +31.9% | +97.8% | +182.5% | +10000.0% | |
| Annual EPS | $1.36 | +463.9% | +230.1% | +185.2% | +213.4% | |
| Annual EBIT | $84.28M | +214.8% | +149.4% | +134.2% | +285.4% | |
| Annual Net Income | $226.45M | +469.5% | +234.9% | +196.3% | +601.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $100.16M | at high | |
| 5Y | $100.16M | at high | |
| All | $100.16M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$221.57M | N/A | +145.2% |
| 5Y | -$283.65M | N/A | +135.3% |
| All | -$289.70M | +134.6% |
EBITDA History
FAQ
What is the current annual EBITDA of ACAD?
As of today, ACAD annual EBITDA is $100.16M
What is 1-year change in ACAD annual EBITDA?
ACAD annual EBITDA is up +247.67% year-over-year
What is 3-year change in ACAD annual EBITDA?
ACAD annual EBITDA is up +159.94% over the past 3 years
How far is ACAD annual EBITDA from its all-time high?
ACAD annual EBITDA is currently at its all-time high
How does ACAD annual EBITDA rank versus sector peers?
ACAD annual EBITDA is higher than 86.36% of companies in Healthcare sector
When is ACAD next annual earnings release?
The next annual earnings release for ACAD is on
Quarterly EBITDA
$38.71M$3.40M+9.62%
Summary
- Current Value
- As of today, ACAD quarterly EBITDA is $38.71M, up +9.62% on
- Historical Performance
- ACAD quarterly EBITDA is up +13.13% year-over-year, and up +227.49% over the past 3 years
- All-Time High Comparison
- ACAD quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ACAD quarterly EBITDA is +169.10% above its 3-year low of -$56.02M reached on
- Sector Comparison
- ACAD quarterly EBITDA is higher than 84.66% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $38.71M | +9.6% | +13.1% | +227.5% | +219.6% | |
| Annual EBITDA | $100.16M | – | +247.7% | +159.9% | +141.1% | |
| TTM EBITDA | $108.46M | +4.3% | -12.9% | +149.3% | +149.2% | |
| Price | $27.42 | +27.3% | +57.7% | +58.5% | -50.1% | |
| PE Ratio | 17.64 | +27.3% | +37.9% | – | – | |
| Quarterly Revenue | $278.63M | +5.3% | +11.3% | +113.2% | +131.1% | |
| Quarterly EPS | $0.42 | +166.0% | +113.3% | +350.5% | +178.6% | |
| Quarterly EBIT | $35.76M | +10.4% | +13.0% | +215.8% | +208.0% | |
| Quarterly Net Income | $71.78M | +169.2% | +119.1% | +364.1% | +184.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $38.71M | at high | |
| 3Y | $38.71M | at high | |
| 5Y | $38.71M | at high | |
| All | $38.71M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $12.20M | N/A | +217.2% |
| 3Y | -$56.02M | +169.1% | |
| 5Y | -$112.50M | +134.4% | |
| All | -$112.50M | +134.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ACAD?
As of today, ACAD quarterly EBITDA is $38.71M
What is ACAD quarterly EBITDA most recent change?
ACAD quarterly EBITDA was up +9.62% on September 30, 2025
What is 1-year change in ACAD quarterly EBITDA?
ACAD quarterly EBITDA is up +13.13% year-over-year
How far is ACAD quarterly EBITDA from its all-time high?
ACAD quarterly EBITDA is currently at its all-time high
How does ACAD quarterly EBITDA rank versus sector peers?
ACAD quarterly EBITDA is higher than 84.66% of companies in Healthcare sector
When is ACAD next earnings release?
The next earnings release for ACAD is on
TTM EBITDA
$108.46M$4.49M+4.32%
Summary
- Current Value
- As of today, ACAD TTM EBITDA is $108.46M, up +4.32% on
- Historical Performance
- ACAD TTM EBITDA is down -12.91% year-over-year, and up +149.27% over the past 3 years
- All-Time High Comparison
- ACAD TTM EBITDA is currently -12.91% below its historical high of $124.54M set on
- 3-Year Low Comparison
- ACAD TTM EBITDA is +148.95% above its 3-year low of -$221.57M reached on an earlier date
- Sector Comparison
- ACAD TTM EBITDA is higher than 84.48% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $108.46M | +4.3% | -12.9% | +149.3% | +149.2% | |
| Annual EBITDA | $100.16M | – | +247.7% | +159.9% | +141.1% | |
| Quarterly EBITDA | $38.71M | +9.6% | +13.1% | +227.5% | +219.6% | |
| Price | $27.42 | +27.3% | +57.7% | +58.5% | -50.1% | |
| PE Ratio | 17.64 | +27.3% | +37.9% | – | – | |
| TTM Revenue | $1.05B | +2.8% | +12.7% | +104.7% | +149.9% | |
| TTM EPS | $1.55 | +16.8% | +101.2% | +215.3% | +190.7% | |
| TTM EBIT | $94.41M | +4.5% | -15.9% | +142.5% | +142.3% | |
| TTM Net Income | $261.17M | +17.6% | +103.2% | +220.2% | +197.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $108.46M | at high | |
| 3Y | $124.54M | -12.9% | |
| 5Y | $124.54M | -12.9% | |
| All | $124.54M | -12.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $100.16M | N/A | +8.3% |
| 3Y | -$221.57M | N/A | +148.9% |
| 5Y | -$221.57M | +148.9% | |
| All | -$309.03M | +135.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ACAD?
As of today, ACAD TTM EBITDA is $108.46M
What is ACAD TTM EBITDA most recent change?
ACAD TTM EBITDA was up +4.32% on September 30, 2025
What is 1-year change in ACAD TTM EBITDA?
ACAD TTM EBITDA is down -12.91% year-over-year
How far is ACAD TTM EBITDA from its all-time high?
ACAD TTM EBITDA is currently -12.91% below its historical high of $124.54M set on September 30, 2024
How does ACAD TTM EBITDA rank versus sector peers?
ACAD TTM EBITDA is higher than 84.48% of companies in Healthcare sector
When is ACAD next earnings release?
The next earnings release for ACAD is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ACAD Official Website www.acadia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1070494/000119312525267453/0001193125-25-267453-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1070494/000095017025029253/0000950170-25-029253-index.htm
- ACAD Profile on Yahoo Finance finance.yahoo.com/quote/ACAD
- ACAD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/acad